SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

AGM Trading Update

20 May 2025 07:00

RNS Number : 2492J
Forterra plc
20 May 2025
 

20 May 2025

FORTERRA PLC

 

AGM Trading Update

 

An encouraging start to the year

 

Ahead of our AGM which will be held today at 12.00pm in Northampton, Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the four-month period ended 30 April 2025 ('the Period').

 

Revenue in the Period of £124.1m was 22% ahead of the prior year (£102.0m) with a strong performance in both our Bricks and Blocks and Bespoke Products operating segments.

 

Trading saw continued positive momentum with the Group benefitting from an improving demand environment, primarily driven by housebuilding with RM&I demand remaining subdued. Our own performance is consistent with an improving market backdrop, in which domestic brick despatches to the end of March, as reported by the Department for Business and Trade, increased 17% year on year albeit against soft comparatives.

 

We continue to implement the necessary selling price increases to offset cost inflation, which remains at normalised levels in line with our expectations. With demand recovering and inventories reducing we are actively managing production capacity to ensure we continue to address customer demand. We have recently taken steps to increase our production of concrete floor beams, and we are preparing to increase our brick production at Desford and expect to utilise both kilns simultaneously for the first time from Q4 2025. Whilst full output is not yet required, this marks an important milestone in the ramp-up of this facility.

 

We have made good progress with the reinstatement of our Wilnecote brick factory following an investment of around £30m, with the kiln expected to be lit imminently. We expect to begin regaining our position in the attractive commercial and specification market as the year progresses. Similarly, the commissioning of our innovative brick slip production facility at our Accrington factory continues to progress in line with our expectations as we develop the product range ahead of a market launch later this year.

 

Notwithstanding normal seasonal trends, we continue to reduce our leverage, with net debt before leases at 30 April 2025 of £88.4m (31 December 2024: £84.9m) and 30 April 2024: £118.5m) equating to 1.7 times EBITDA on a rolling 12 months' banking covenant basis (31 December 2024: 1.9 times). 

 

Outlook

 

We are encouraged by the positive start to the year and expect to continue to benefit from an improving demand environment whilst noting that the prior year comparatives become more challenging as the year progresses. We remain mindful of the presently heightened global macro-economic uncertainty and the impact this could have on the wider economy. Accordingly, at this stage in the year, the Board's expectations for the Group's full year 2025 performance remain unchanged.

 

Our key markets continue to benefit from attractive fundamentals including the Government's commitment to materially increase housebuilding, although we remain mindful of the challenges in delivering this. Following our recent strategic investments in additional manufacturing capacity, the Group remains ideally positioned to benefit from continued market recovery.

 

ENQUIRIES

 

 

 

Forterra plc

+44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting

+44 203 727 1340

Richard Mountain / Nick Hasell

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTALMTTMTMBBMA
Date   Source Headline
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company
8th Jul 20203:02 pmRNSHolding(s) in Company
8th Jul 202010:32 amRNSHolding(s) in Company
7th Jul 20203:27 pmRNSHolding(s) in Company
7th Jul 20203:25 pmRNSHolding(s) in Company
7th Jul 20202:20 pmRNSTotal Voting Rights and Capital
7th Jul 202012:44 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 20203:34 pmRNSDirector Shareholdings
6th Jul 20203:32 pmRNSPCA Shareholdings
2nd Jul 20207:00 amRNSResults of Placing
1st Jul 20204:41 pmRNSProposed placing of new ordinary shares
1st Jul 20204:40 pmRNSFinancing update and proposed equity placing
25th Jun 202010:44 amRNSHolding(s) in Company
24th Jun 20208:02 amRNSHolding(s) in Company
22nd Jun 20203:27 pmRNSHolding(s) in Company
16th Jun 20207:55 amRNSHolding(s) in Company
10th Jun 202012:53 pmRNSHolding(s) in Company
10th Jun 202012:45 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSTrading Update
26th May 20202:25 pmRNSDirector/PDMR Shareholding
14th May 20201:45 pmRNSResult of AGM
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSRecommencement of operations
16th Apr 202012:07 pmRNSSecond Price Monitoring Extn
16th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20207:00 amRNSAnnual Report 2019 and AGM 2020
26th Mar 20209:07 amRNSHolding(s) in Company
24th Mar 20202:50 pmRNSUpdate on Covid-19
24th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20205:41 pmRNSDirector/PDMR Shareholding
13th Mar 20209:55 amRNSHolding(s) in Company
13th Mar 20209:51 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNS2019 FULL YEAR RESULTS
3rd Mar 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Feb 20209:23 amRNSHolding(s) in Company
6th Feb 202010:59 amRNSEmployee Benefit Trust Share Purchase
30th Jan 20202:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.